| Symbol |
Name |
Standardized Value |
|
TP53
|
tumor protein p53
|
4.12
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
3.52
|
|
TP53I3
|
tumor protein p53 inducible protein 3
|
2.93
|
|
EPN3
|
epsin 3
|
2.56
|
|
ASB8
|
ankyrin repeat and SOCS box containing 8
|
2.25
|
|
ZNF296
|
zinc finger protein 296
|
2.24
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.99
|
|
PHLDA3
|
pleckstrin homology-like domain, family A, member 3
|
1.94
|
|
CD82
|
CD82 molecule
|
1.89
|
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5
|
1.89
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.89
|
|
CAPN5
|
calpain 5
|
1.85
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
1.84
|
|
RBIS
|
ribosomal biogenesis factor
|
1.82
|
|
F10
|
coagulation factor X
|
1.81
|
|
TNFRSF10D
|
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain
|
1.81
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
1.77
|
|
FAS
|
Fas cell surface death receptor
|
1.77
|
|
RND3
|
Rho family GTPase 3
|
1.76
|
|
ZBTB5
|
zinc finger and BTB domain containing 5
|
1.74
|
|
SNAI1
|
snail family zinc finger 1
|
1.73
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
1.72
|
|
EPHB3
|
EPH receptor B3
|
1.7
|
|
RYBP
|
RING1 and YY1 binding protein
|
1.65
|
|
TBX3
|
T-box 3
|
1.6
|
|
TDG
|
thymine-DNA glycosylase
|
1.59
|
|
BRD8
|
bromodomain containing 8
|
1.56
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
1.55
|
|
CSRNP2
|
cysteine-serine-rich nuclear protein 2
|
1.54
|
|
CCND1
|
cyclin D1
|
1.54
|
|
PLK2
|
polo-like kinase 2
|
1.49
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
1.47
|
|
GDF15
|
growth differentiation factor 15
|
1.47
|
|
C4BPA
|
complement component 4 binding protein, alpha
|
1.46
|
|
FDXR
|
ferredoxin reductase
|
1.43
|
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2
|
1.41
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
1.38
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
1.38
|
|
SESN1
|
sestrin 1
|
1.38
|
|
PLCD1
|
phospholipase C, delta 1
|
1.37
|
|
SP6
|
Sp6 transcription factor
|
1.37
|
|
FN1
|
fibronectin 1
|
1.37
|
|
RAET1G
|
retinoic acid early transcript 1G
|
1.34
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
1.33
|
|
BPGM
|
2,3-bisphosphoglycerate mutase
|
1.32
|
|
RAB40C
|
RAB40C, member RAS oncogene family
|
1.31
|
|
SCNM1
|
sodium channel modifier 1
|
1.3
|
|
HSPA4L
|
heat shock 70kDa protein 4-like
|
1.3
|
|
GALNT5
|
polypeptide N-acetylgalactosaminyltransferase 5
|
1.3
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
1.29
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
1.28
|
|
SESN2
|
sestrin 2
|
1.27
|
|
GATA2
|
GATA binding protein 2
|
1.26
|
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
|
1.26
|
|
MATR3
|
matrin 3
|
1.26
|
|
C18ORF32
|
chromosome 18 open reading frame 32
|
1.24
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
1.24
|
|
SQSTM1
|
sequestosome 1
|
1.23
|
|
GLUL
|
glutamate-ammonia ligase
|
1.22
|
|
PREPL
|
prolyl endopeptidase-like
|
1.22
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
1.21
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
1.2
|
|
TRIM21
|
tripartite motif containing 21
|
1.19
|
|
CCN1
|
cellular communication network factor 1
|
1.18
|
|
WSB1
|
WD repeat and SOCS box containing 1
|
1.18
|
|
SLC5A3
|
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3
|
1.18
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
1.17
|
|
MAPKBP1
|
mitogen-activated protein kinase binding protein 1
|
1.17
|
|
IRS2
|
insulin receptor substrate 2
|
1.16
|
|
CPE
|
carboxypeptidase E
|
1.16
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
1.16
|
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4
|
1.16
|
|
COQ8A
|
coenzyme Q8A
|
1.15
|
|
GLRX
|
glutaredoxin (thioltransferase)
|
1.14
|
|
ARHGEF28
|
Rho guanine nucleotide exchange factor (GEF) 28
|
1.14
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
1.13
|
|
SAT2
|
spermidine/spermine N1-acetyltransferase family member 2
|
1.11
|
|
LRP10
|
low density lipoprotein receptor-related protein 10
|
1.11
|
|
CHST14
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14
|
1.11
|
|
HBA1
|
hemoglobin, alpha 1
|
1.11
|
|
PER2
|
period circadian clock 2
|
1.11
|
|
RAB27B
|
RAB27B, member RAS oncogene family
|
1.11
|
|
PML
|
promyelocytic leukemia
|
1.11
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
1.1
|
|
CMBL
|
carboxymethylenebutenolidase homolog (Pseudomonas)
|
1.1
|
|
TOB1
|
transducer of ERBB2, 1
|
1.1
|
|
LACC1
|
laccase (multicopper oxidoreductase) domain containing 1
|
1.1
|
|
ZNF697
|
zinc finger protein 697
|
1.09
|
|
EPPK1
|
epiplakin 1
|
1.08
|
|
MSX1
|
msh homeobox 1
|
1.08
|
|
SLC30A1
|
solute carrier family 30 (zinc transporter), member 1
|
1.07
|
|
LRATD2
|
LRAT domain containing 2
|
1.06
|
|
CCND3
|
cyclin D3
|
1.06
|
|
ASB7
|
ankyrin repeat and SOCS box containing 7
|
1.05
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
1.04
|
|
C5
|
complement component 5
|
1.04
|
|
PLCL2
|
phospholipase C-like 2
|
1.04
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
1.04
|
|
GNL3L
|
guanine nucleotide binding protein-like 3 (nucleolar)-like
|
1.03
|
|
CCNDBP1
|
cyclin D-type binding-protein 1
|
1.02
|